RAB35 and gastrointestinal stromal tumor: USP32 promotes the exocrine secretion of imatinib-resistant gastrointestinal stromal tumors by decreasing the Lys48 (K48) ubiquitination of Rab35, protecting it from proteasome destruction (Fig. 6).